Advertisement
Screener

Apogee Therapeutics, Inc. (APGE) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Apogee Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Apogee Therapeutics, Inc. (APGE) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 7.22 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-10

  • Apogee Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 7.22M shares, a 3.64% increase year-over-year.
  • Apogee Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 7.65M shares, a 11.92% increase year-over-year.
  • Apogee Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 6.73M shares, a 34.28% increase year-over-year.
  • Apogee Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 6.97M shares, a 42.04% increase year-over-year.
  • Apogee Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 6.43M shares, a 6.04% decline from fiscal 2024.
  • Apogee Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 6.84M shares, a 37.68% increase from fiscal 2023.
  • Apogee Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 4.97M shares.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 5 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 8 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 11 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month
2026-06-307.22M shares
10-Q · filed 2026-08-10
7.22M shares
10-Q · filed 2026-08-10
2026-03-317.65M shares
10-Q · filed 2026-05-11
2025-12-316.43M shares
10-K · filed 2026-03-02
2025-09-306.73M shares
10-Q · filed 2025-11-10
6.73M shares
10-Q · filed 2025-11-10
2025-06-306.97M shares
10-Q · filed 2026-08-10
6.97M shares
10-Q · filed 2026-08-10
2025-03-316.84M shares
10-Q · filed 2026-05-11
2024-12-316.84M shares
10-K · filed 2026-03-02
2024-09-305.01M shares
10-Q · filed 2025-11-10
5.01M shares
10-Q · filed 2024-11-12
5.01M shares
10-Q · filed 2025-11-10
5.01M shares
10-Q · filed 2024-11-12
2024-06-304.90M shares
10-Q · filed 2025-08-11
4.90M shares
10-Q · filed 2025-08-11
2024-03-314.85M shares
10-Q · filed 2025-05-12
2023-12-314.97M shares
10-K · filed 2026-03-02
2023-09-303.29M shares
10-Q · filed 2024-11-12
3.29M shares
10-Q · filed 2024-11-12
2023-06-3079.36M shares
10-Q · filed 2024-08-12
79.36M shares
10-Q · filed 2024-08-12
2023-03-3176.14M shares
10-Q · filed 2024-05-13
2022-12-3174.74M shares
10-K · filed 2024-03-05
2022-09-3010.00M shares
10-Q · filed 2023-11-13
10.00M shares
10-Q · filed 2023-11-13
2022-06-305.00M shares
10-Q · filed 2023-08-28
5.00M shares
10-Q · filed 2023-08-28